【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Disease overview
• Types of myocardial infarction
• Pathophysiology
• Risk factors
• Diagnosis
• Management
PART 06: Epidemiology and economic burden
• Burden of disease
PART 07: Pipeline analysis
• Canakinumab
• MyoCell
• MultiStem therapy
• CLBS10
• Prochymal
• Revascor
• CicloMulsion
• PP-099
• NP202
• CAP-1002
• Revacept
• CSL112
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by drug class
• Beta blockers
• ACE inhibitors
• ARBs
• Vasodilators
• Antithrombotic agents
• Thrombolytics
• Glycoprotein IIb/IIIa inhibitors
• Anti-dyslipidemic drugs
• Calcium channel blockers
• Analgesics
PART 10: Market segmentation by EKG appearance
• NSTEMI
• STEMI
PART 11: Market segmentation by type
• Brand-name drugs
• Generic drugs
PART 12: Geographical segmentation
• Global myocardial infarction drugs market segmentation by geography 2015-2020
• Myocardial infarction drugs market in Americas
• Myocardial infarction drugs market in EMEA
• Myocardial infarction drugs market in APAC
PART 13: Market drivers
• Increase in older population
• Sedentary lifestyle
• Rise in obesity
• High prevalence of chronic conditions
PART 14: Impact of drivers
PART 15: Market challenges
• Delayed diagnosis
• Alternative therapies
• Extensive use of generics
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Growing awareness of disease
• Strategic alliances
• Increased R&D
• Prevalent use of stent grafts
PART 18: Vendor landscape
• Competitive scenario
• AstraZeneca
• Bayer HealthCare
• Eli Lilly
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for myocardial infarction drugs
Exhibit 03: Pathophysiology of myocardial infarction
Exhibit 04: Risk factors of myocardial infarction
Exhibit 05: Diagnostic techniques for myocardial infarction
Exhibit 06: Treatment options for myocardial infarction
Exhibit 07: Projected prevalence of CVDs in US
Exhibit 08: Projected economic burden for CVDs in US
Exhibit 09: Pipeline portfolio: Myocardial infarction
Exhibit 10: Global myocardial infarction drugs market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Global myocardial infarction drugs market segmentation by EKG appearance 2015
Exhibit 13: Global myocardial infarction drugs market segmentation by type 2015
Exhibit 14: Global myocardial infarction drugs market segmentation by geography 2015
Exhibit 15: Myocardial infarction drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 16: Myocardial infarction drugs market in Americas 2015-2020 ($ billions)
Exhibit 17: Myocardial infarction drugs market in EMEA 2015-2020 ($ billions)
Exhibit 18: Myocardial infarction drugs market in APAC 2015-2020 ($ billions)
Exhibit 19: Global myocardial infarction drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: AstraZeneca: Business segmentation by revenue 2014
Exhibit 23: AstraZeneca: Cardiovascular and metabolic diseases segment by revenue 2014
Exhibit 24: AstraZeneca: YoY revenue and growth rate of Crestor 2012-2014 ($ billions)
Exhibit 25: AstraZeneca: YoY revenue and growth rate of Seloken/Toprol 2012-2014 ($ millions)
Exhibit 26: AstraZeneca: YoY revenue and growth rate of Atacand 2012-2014 ($ millions)
Exhibit 27: AstraZeneca: YoY revenue and growth rate of Brilinta/Brilique 2012-2014 ($ millions)
Exhibit 28: AstraZeneca: Key takeaways
Exhibit 29: Bayer HealthCare: YoY revenue and growth rate of Xarelto 2012-2014 ($ millions)
Exhibit 30: Bayer HealthCare: YoY revenue and growth rate of Adalat 2012-2014 ($ millions)
Exhibit 31: Bayer HealthCare: Key takeaways
Exhibit 32: Eli Lilly: YoY revenue and growth rate of Effient (global) 2012-2015 ($ millions)
Exhibit 33: Eli Lilly: YoY revenue and growth rate of Effient in US 2012-2015 ($ millions)
Exhibit 34: Eli Lilly: YoY revenue and growth rate of Effient in rest of world 2012-2015 ($ millions)
Exhibit 35: Eli Lilly: Key takeaways
Exhibit 36: Novartis: YoY revenue and growth rate of Diovan 2012-2015 ($ billions)
Exhibit 37: Novartis: YoY revenue and growth rate of Exforge 2012-2015 ($ billions)
Exhibit 38: Novartis: Key takeaways
Exhibit 39: Pfizer: YoY revenue and growth rate of Lipitor 2012-2014 ($ billions)
Exhibit 40: Pfizer: YoY revenue and growth rate of Norvasc 2012-2014 ($ billions)
Exhibit 41: Pfizer: YoY revenue and growth rate of Fragmin 2012-2014 ($ millions)
Exhibit 42: Pfizer: YoY revenue and growth rate of Caduet 2012-2014 ($ millions)
Exhibit 43: Pfizer: Key takeaways
Exhibit 44: Sanofi: YoY revenue and growth rate of Plavix 2012-2014 ($ billions)
Exhibit 45: Sanofi: YoY revenue and growth rate of Lovenox 2012-2014 ($ billions)
Exhibit 46: Sanofi: Key takeaways
【レポート販売概要】
■ タイトル:心筋梗塞治療薬の世界市場2016-2020■ 英文:Global Myocardial Infarction Drugs Market 2016-2020
■ 発行日:2016年3月8日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8952
■ 調査対象地域:グローバル
- ソナー装置の世界市場予測(~2022年)“Sonar system market is projected to grow at a CAGR of 4.33% during the forecast period.”The sonar system market is projected to grow from USD 3.49 billion in 2016 to USD 3.72 billion by 2022, at a CAGR of 4.33% from 2017 to 2022. The growth in this market can be attributed to the rising demand for sonar systems in tactical defense operations, increased adoption of sonars for Anti-Submarine Warfar …
- 胃食道逆流症(GERD)治療薬の世界市場分析:薬の種類別(制酸薬、プロトンポンプ阻害薬、H2受容体遮断薬、プロキネティック薬)、地域別、セグメント予測、2014-2025The global Gastroesophageal Reflux Disease (GERD) therapeutics market is expected to reach USD 4.34 billion by 2025, according to a new study by Grand View Research, Inc. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime. The overall market has been experiencing …
- 2014年戦略提言:世界の止血診断検査市場Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100.SummaryThis comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years. The report explores bus …
- Wi-Fiホットスポットの世界市場:無線ホットスポットゲートウェイ、無線ホットスポットコントローラ、モバイルホットスポット端末The report on the Wi-Fi Hotspot market focuses on various Wi-Fi components, software solutions, services, verticals, and end users that are driving this market. NA, Europe, and APAC are the top three regions that hold the largest market share in the year 2015. The growth of mobile devices such as smartphones and tablets has fueled the demand for new wireless networking equipment that supports high …
- ドイツの免疫診断市場2014This report provides an overview of the German immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Table of ContentsBusiness Environment Market StructureMarket Size, Growth, Major Suppliers'Instrument and Reagent Sales an …
- 鉄道車両シートの世界市場:一般シート、リクライナーシート、折たたみシート、食堂用シート、スマートシートThe global train seat market was valued at USD 938.2 Million in 2015 and is expected to reach USD 1,047.7 Million by 2022, at a CAGR of 1.58% from 2016 to 2022. Governments worldwide are actively involved in the development of faster and convenient modes of transportation by investing in rail infrastructure projects. Trains play a vital role in the transportation system by offering long-term conve …
- 世界の三次元イメージング市場:3Dモデリング、3Dスキャン、3DレンダリングWith a surge in demand for 3D technologies and global adoption towards 3D, 3D imaging is witnessing a fast paced traction across all industry verticals such as Healthcare, Public safety and defense, Building and construction, thereby making its presence ubiquitous. 3D imaging solution has been commercialized in most of the products such as smartphones, TVs, animation, gaming, computers, cameras, c …
- Wi-Fiエクステンダー(中継機)の世界市場2017-2021About Wi-Fi Extenders A wireless range extender takes an existing signal from a wireless router or wireless access point (AP) and rebroadcasts it to create a second network. A user can opt for the extender to either clone the existing network or make a distinct hotspot with its own network name and password. Opting for the former means the extender will use the same network name and password as th …
- 世界の溶媒蒸発市場:蒸発器種類別(ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器)、エンドユーザー別(医薬&バイオ医薬品、診断研究所、研究所&学術研究所)、地域別“The global solvent evaporators market size is projected to grow at a CAGR of 7.3%.” The global solvent evaporators market size is expected to reach USD 694 million by 2024 from an estimated USD 487 million in 2019, at a CAGR of 7.3%. The growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large mol …
- 世界における小型自動車用トランスミッション及びクラッチ市場動向と予測(~2029)This latest just-auto report edition offers a global review of the OE transmissions sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE transmissions market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and pro …
- 卵巣がん治療薬の世界市場:企業動向、研究開発、収益予測Ovarian Cancer Therapies – Explore Potentials of New Drugs, Industry Changes and Emerging Opportunities What’s the future for treating cancer of the human ovaries? Visiongain’s new study forecasts those pharmaceutical revenues. There you find outlooks for sales growth in that industry. You also explore trends, results, treatments, R&D, and opportunities, seeing prospects. Our report gives revenue …
- インテリジェントパワーモジュールの世界市場:定格電圧、定格電流、回路構成、パワーデバイス(IGBT、MOSFT)、産業、地域別分析According to the MarketsandMarkets forecast, the intelligent power modules market, in terms of value, is expected to grow from USD 1.33 Billion in 2015 to USD 2.42 Billion by 2022, at a CAGR of 9.0% between 2016 and 2022. IPMs enable an overall improvement in the system reliability and performance. The integration of the protection and drive circuitries directly into IPM enables the reduction in d …
- 蒸着装置の世界市場:化学蒸着(CVD)装置、物理蒸着(PVD)装置Globally vapor deposition technologies can be classified in two major segments, Chemical vapor deposition (CVD) and Physical vapor deposition (PVD), these technologies are used in various end-use industries such as microelectronics, cutting tools, industrial & energy, medical devices & equipment, decorative coating and others (packaging, composites, catalysts, powder production and R&D), for apply …
- 塞栓療法の世界市場予測(~2024年)“The embolotherapy market is projected to grow at a CAGR of 8.1% during the forecast period”The embolotherapy market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. …
- 世界の導体ウエハ洗浄装置市場2015The Global Semiconductor Wafer Cleaning Systems Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Semiconductor Wafer Cleaning Systems industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Semiconductor Wafer Cleaning Systems market analysis is provided …